SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Small GW. Recognizing and treating anxiety in the elderly. J. Clin. Psychiatry 1997; 58 (Suppl. 3): 4147.
  • 2
    Mintzer JE, Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: Toward a treatment approach. J. Clin. Psychiatry 1996; 57 (Suppl. 7): 5563.
  • 3
    Flint AJ. Generalised anxiety disorder in elderly patients: Epidemiology, diagnosis and treatment options. Drugs Aging 2005; 22: 101114.
  • 4
    Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of generalized anxiety disorder. Int. J. Neuropsychopharmacol. 2005; 8: 293302.
  • 5
    Bohm C, Robinson DS, Gammans RE et al. Buspirone therapy in anxious elderly patients: A controlled clinical trial. J. Clin. Psychopharmacol. 1990; 10 (Suppl. 3): 47S51S.
  • 6
    Cadieux RJ. Azapirones: An alternative to benzodiazepines for anxiety. Am. Fam. Physician 1996; 53: 23492353.
  • 7
    Conde Lopez V, Martinez Roig M. Azaspirodecanodiones in clinical psychiatry. Actas Luso Esp. Neurol. Psiquiatr. Cienc. Afines 1992; 20: 155167.
  • 8
    Napoliello MJ, Domantay AG. Buspirone: A worldwide update. Br. J. Psychiatry Suppl. 1991; 159 (Suppl. 12): 4044.
  • 9
    Robinson D, Napoliello MJ, Schenk J. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. Clin. Ther. 1988; 10: 740746.
  • 10
    Majercsik E, Haller J. Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004; 28: 11611169.
  • 11
    Lenze EJ, Mulsant BH, Shear MK et al. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: Results from an 8-week randomized, placebo-controlled trial. Am. J. Psychiatry 2005; 162: 146150.
  • 12
    Ragneskog H, Eriksson S, Karlsson I, Gottfries CG. Long-term treatment of elderly individuals with emotional disturbances: An open study with citalopram. Int. Psychogeriatr. 1996; 8: 659668.
  • 13
    Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am. J. Psychiatry 2001; 158: 20082014.
  • 14
    Krishnan KR, Doraiswamy PM, Clary CM. Clinical and treatment response characteristics of late-life depression associated with vascular disease: A pooled analysis of two multicenter trials with sertraline. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001; 25: 347361.
  • 15
    Finkel SI, Richter EM, Clary CM. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older. Int. Psychogeriatr. 1999; 11: 8599.
  • 16
    Lapierre YD. Controlling acute episodes of depression. Int. Clin. Psychopharmacol. 1991; 6 (Suppl. 2): 2335.
  • 17
    Brawman-Mintzer O. Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly. National Institutes of Health, Bethesda, 2009. [Cited 17 June 2008.] Available from URL: http://clinicaltrials.gov/ct2/show/study/NCT00701675
  • 18
    Davidson JR, DuPont RL, Hedges D, Haskins JT. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J. Clin. Psychiatry 1999; 60: 528535.
  • 19
    Lader M, Scotto JC. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology (Berl) 1998; 139: 402406.
  • 20
    Markovitz PJ. Treatment of anxiety in the elderly. J. Clin. Psychiatry 1993; 54 (Suppl.): 6468.
  • 21
    Majercsik E, Haller J, Leveleki C, Baranyi J, Halasz J, Rodgers RJ. The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003; 27: 11871199.
  • 22
    Khouzam HR, Emes R. The use of buspirone in primary care. J. Psychosoc. Nurs Ment. Health Serv. 2002; 40: 3441.
  • 23
    Rickels K, Rynn M. Pharmacotherapy of generalized anxiety disorder. J. Clin. Psychiatry 2002; 63 (Suppl. 14): 916.
  • 24
    Syvalahti E, Penttila J, Majasuo H, Palvimaki EP, Laakso A, Hietala J. Combined treatment with citalopram and buspirone: Effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain. Pharmacopsychiatry 2006; 39: 18.
  • 25
    Boyer P, Tassin JP, Falissart B, Troy S. Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression. J. Clin. Pharm. Ther. 2000; 25: 363371.
  • 26
    Holzer JC, Gitelman DR, Price BH. Efficacy of buspirone in the treatment of dementia with aggression. Am. J. Psychiatry 1995; 152: 812.
  • 27
    Cooper JP. Buspirone for anxiety and agitation in dementia. J. Psychiatry Neurosci. 2003; 28: 469.